CHD demands FDA WITHDRAW its approval of remdesivir for children – Dr. Eddy Bettermann MD

Pro-health freedom group Children’s Health Defense (CHD) demanded that the Food and Drug Administration (FDA) withdraw its approval of the antiviral drug remdesivir for children

Setty cited guidance by the World Health Organization (WHO) recommending against the use of remdesivir for hospitalized COVID-19 patients. Back in November 2020, the global health body said “there is currently no evidence that remdesivir improves survival and other outcomes in these patients, regardless of disease severity.”

According to Ardis, remdesivir causes acute kidney failure within five to 10 days in 35 percent of patients administered with it alone. When combined with dexamethasone and vancomycin, it causes acute kidney failure in up to 45 percent of patients in a span of five days. The resulting renal failure causes the bodies of hospitalized COVID-19 patients to retain water, added the chiropractor.

“When you cause acute kidney failure with drugs that they’re using in ICUs while they have an intravenous drip that is putting water into their body – their abdomen, heart and lungs eventually fill up with water. [Hospitals] are misdiagnosing that as COVID pneumonia that you continue to hear – [when] it’s actually pulmonary edema.”

Watch Dr. Bryan Ardis below telling Jeffrey Pedersen and Shannon Townsend of remdesivir’s dangers on the Brighteon.TV program “The Matrixxx Grooove Show.”

CHD demands FDA WITHDRAW its approval of remdesivir for children – Dr. Eddy Bettermann MD